AXSM
Axsome Therapeutics Inc
179.30$
-1.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | 13.1% | 10.4% | 9.6% | 8.6% | 7.4% | |
| – | – | – | – | – | – | – | – | -13.1% | 89.6% | 90.4% | 91.4% | 92.6% | |
| – | – | – | – | – | – | – | – | 658.3% | 115.8% | 36.2% | 48.5% | 28.7% | |
| – | – | – | – | – | – | – | – | 755.6% | 247.7% | 82.3% | 80.4% | 89.4% | |
| – | – | – | – | – | – | – | – | 1,413.9% | 448.9% | 176.0% | 164.1% | 119.1% | |
| – | – | – | – | – | – | – | – | -1,413.9% | -359.3% | -85.7% | -72.7% | -26.5% | |
| – | – | – | – | – | – | – | – | 64.6% | 14.7% | 2.4% | 1.7% | 1.0% | |
| – | – | – | – | – | – | – | – | -1,478.5% | -374.0% | -88.1% | -74.4% | -28.8% | |
| – | – | – | – | – | – | – | – | 51.5% | 21.2% | 0.4% | 0.0% | -0.1% | |
| – | – | – | – | – | – | – | – | -1,530.0% | -374.0% | -88.4% | -74.5% | -28.7% | |
| – | – | – | – | – | – | – | – | -1,400.8% | -350.5% | -83.1% | -70.7% | -26.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.